Triumph Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.61K Buy
39
+4
+11% +$1.11K ﹤0.01% 1194
2026
Q1
$10.3K Buy
35
+5
+17% +$1.49K ﹤0.01% 1112
2025
Q4
$8.19K Buy
+30
New +$8.15K ﹤0.01% 1141

Other funds holding CME

Triumph Capital Management's CME Position: Q2 2026 in Review

Triumph Capital Management increased its CME Group (CME) stake by 11% in Q2 2026, buying an estimated $1.11K and bringing the position to 39 shares worth $8.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Triumph Capital Management first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.3K in Q1 2026. 382 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Triumph Capital Management held 39 shares of CME Group worth $8.61K as of Q2 2026.
  • Triumph Capital Management bought 4 CME Group shares in Q2 2026, an estimated $1.11K.
  • CME Group made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1194 holding.
  • Triumph Capital Management first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Triumph Capital Management's CME Group position peaked at $10.3K in Q1 2026.
  • 382 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.